Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine
Jump to navigation
Jump to search
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Protein subunit |
| Clinical data | |
| Routes of administration | Intramuscular |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by Zhongyianke Biotech, Liaoning Maokangyuan Biotech, and Academy of Military Medical Sciences.[1][2]
References[edit]
- ^ "Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 13 April 2021.
- ^ "Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 13 April 2021.
 |
Scholia has a profile for Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine (Q106652103). |
.png){kind=small} | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |